Abstract: A nanoemulsion containing a quaternary ammonium salt with at least a twenty carbon chain is effective to prevent the growth of biofilms.

Abstract: Formulations comprising a combination of red propolis and red algae, e.g., L. calcareum, as active ingredients, and methods of treatment using the same are provided herein. In various embodiments, the formulation may be in the form of, e.g., an aqueous solution or suspension, an ingestible solid or liquid form, or a topical preparation, and may be used to treat a variety of diseases and conditions responsive to the combination.

Abstract: The present invention relates to a process for preparing solid microcapsules comprising the following steps: a) preparation of a composition C1, which is either a composition C1a, comprising a single hydrophobic solid particle, or a composition C1b comprising a plurality of hydrophobic solid particles dispersed in a hydrophilic phase, b) addition with stirring of the composition C1 in a polymeric composition C2 at a temperature Tb, whereby an emulsion (E1) is obtained; c) addition, with stirring, of the emulsion (E1) in a composition C3 at a temperature Tc, whereby a double emulsion (E2) is obtained; d) applying a shear to the emulsion (E2), whereby a double emulsion (E3) is obtained; and e) polymerization of the composition C2, whereby solid microcapsules dispersed in the composition C3 are obtained.

Abstract: A method of combatting colour loss from a dyed material, the method comprising the steps of: (1) contacting the material with a composition comprising an electrophilic species selected from aldehydes, succinimidyl esters, and mixtures thereof; (2) contacting the material with a composition comprising a chelating agent and/or a salt of an amine and/or a carboxylic acid.

Abstract: Pharmaceutical compositions and dosage forms of dimethyl fumarate containing low levels of certain impurities are disclosed.

Abstract: It is an object of the present invention to provide a capsule comprising a functional substance and having good shape stability and a good feeling of use. A method for producing a capsule, comprising steps of mixing gelatin and a functional substance; adding a carbodiimide crosslinking agent to crosslink the gelatin with the carbodiimide crosslinking agent; solidifying the crosslinked gelatin; and grinding the solidified gelatin.

Abstract: A formulation that is a water soluble, solid formulation having a first component of one or more compounds selected from thickening agents and anti-drying agents including, but are not limited to, glycerins, propylene glycol, fatty acids, salts of fatty acids, sugars, and other components and a second component of an animal attractant or an animal or insect repellant. When an apparatus to dispense the formulation is used, it is either a post embedded into the formulation or a fastener mounted with respect to the solid mixture, where the fastener is configured to suspend the solid mixture.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer and a method for producing same, the composition comprising tetraarsenic hexoxide in which the content of tetraarsenic hexoxide crystalline polymorph a (As4O6-a) is 99% or more. The composition of the present invention exhibits an excellent cancer cell proliferation inhibition effect and thus can be useful as an anticancer drug.

Abstract: The disclosure relates to compositions for treating keratinous substrates, such as the hair, comprising monoethanolamine and at least one carboxylic acid, as well as systems and methods for treating keratinous substrates with the compositions.

Abstract: Various embodiments of the present disclosure are to provide a tumor microenvironment-responsive nanocomplex capable of presenting a novel paradigm for tumor therapy by reprogramming tumor microenvironments and an anticancer composition containing the same.

Abstract: The present invention relates to a drug delivery kit including an enzyme, and more particularly a drug delivery system using a drug delivery system kit, which includes a drug delivery system including a core and a coating layer; and an enzyme having a degradation activity against the coating layer.

Abstract: Activated hydrogen peroxide disinfecting compositions are provided especially for low-foaming applications. A concentrate for dilution by an end-user is provided, which includes a hydrogen peroxide source, a non-surfactant organic sulfonic acid or salt thereof, a non-ionic surfactant, and an optional organic acid. Also provided is a ready-to-use hydrogen peroxide, disinfectant solution including a biocidal amount of hydrogen peroxide, a non-surfactant organic sulfonic acid or salt thereof, a non-ionic surfactant, water as solvent and an optional organic acid. An end-user can disinfect a surface of microorganisms by contacting the surface with the disinfecting composition for an amount of time effective to kill a majority of the microbes located on the surface.

Abstract: An antiperspirant/deodorant composition in the form of stick, cream, or flowable gel may include a carrier that may include a polyhydric alcohol or a mixture of a polyhydric alcohol and water; a thickening agent including a C14-22 fatty acid salt; and an antiperspirant active dispersed in the carrier. The antiperspirant active may include a layered silicate clay and/or an acyl substituted polyvinylpyrrolidone. The antiperspirant/deodorant composition may be primarily free of a C1-5 monohydric alcohol and a metal salt based antiperspirant active, such as aluminum-based antiperspirant active.

Abstract: In an ultraviolet-shielding particle coated with silicon oxide of the present invention, a surface of the ultraviolet-shielding particle is coated with a silicon oxide coat, at least one functional group selected from the group consisting of an alkyl group, an alkenyl group, and a cycloalkyl group is present on a surface of the silicon oxide coat, and a content of the functional group is 0.0001% by mass or more and 0.30% by mass or less.

Abstract: The present invention concerns a new biomaterial used to manufacture antimicrobial dental devices, intended to control the growth of microorganisms in the oral cavity. These include removable dentures (RD) with copper nanoparticles technology and antimicrobial properties against dental pathogens, such as: Candida albicans, a pathogen responsible for denture stomatitis; Pathogenic Streptococcus mutans, responsible for the initiation and progression of caries formation; and Staphylococcus aureus, which causes periprosthetic infections. This removable dental material allows for the production of a new dental device to prevent and/or control oral infections caused by said pathogens, such as denture stomatitis, secondary caries, periodontal diseases, among others.

Abstract: A disinfectant formulation is provided imparting a residual biocidal property. The disinfectant formulation is used to treat a surface to impart a film having a capacity to quickly kill bacteria and other germs for at least 24 hours after deposit of the film on a treated surface. The disinfectant formulation comprises a polymer binder, wherein the polymer binder is an oxazoline homopolymer or an extended or a modified polymer based on an oxazoline homopolymer, and a biocidal compound. The disinfectant formulation further comprises a carrier. An article having the disinfectant formulation is provided as well as methods of making, using and applying the disinfectant formulation.

Abstract: Disclosed is a method of obtaining an inorganic nanostructured complex (CFI-1), a protein-associated nanostructured complex (MRB-CFI-1) and antitumor use. The main use is in treating urinary bladder cancer, both in animals and humans. The complex has singular antitumor activity, and can potentially be used as a substitute and/or act as an adjuvant for other commercial antineoplastic drugs.

Abstract: A biofilm sealant is provided imparting a residual biocidal property. The biofilm sealant is used to treat a surface to impart a film having a capacity to quickly kill bacteria and other germs for at least 24 hours after deposit of the film on a treated surface. The disinfectant formulation biofilm sealant comprises a polymer binder, wherein the polymer binder is an oxazoline homopolymer or an extended or a modified polymer based on an oxazoline homopolymer, and a biocidal compound.

Abstract: This invention relates to skincare compositions, in particular compositions effective in the treatment of acne vulgaris, and to methods of treatment of the skin that involve the application of such compositions, wherein the compositions comprise salicylic acid or a salt thereof in combination with at least two actives selected from the group consisting of lactic acid or a salt thereof; glycyrrhizinic acid or a salt or a derivative thereof; bisabolol; cetylhydroxyproline palmitamide; allantoin; niacinamide; and Epilobium angustifolium extract.

Abstract: The present invention relates to cosmetic or personal care compositions comprising two or more compounds, each compound containing an allylic or partially allylic carbonylsubstructure having the following structure I: wherein Y is a second substructure immediately adjacent to the allylic or partially allyliccarbonyl substructure and is selected from one of the following groups consisting of (i) hydroxyl-based group including —OH or —C(?)—(OH); (ii)carbonyl-based group including —C(?)—C (?O)—CH3; (iii) N ether group, —O—; (iv) sultam group, —N(H)—S(?O)2—; (v) lactam group, —N(H)—C(?O)—; (vi) apolar group including cyclic structures based on menthol or carotenoids; (vii) secondary aldimine containing group including —N(H)—C(NH2)?N— or —N(H)—C(H)?N—; (viii) amine group, —NH2; (ix) secondary amine-based group, —N(H)—; and (x) amide-based group including —N(H)—C(?O)— or —N(H)—C(?O)—N(H)—, their derivatives, isomers, salts and/or combination thereof; and a cosmetically acceptable vehicle.